Treatments primer · HRT & cancer

HRT and cancer risk, in real numbers.

The conversation everyone wants to skip and nobody should. What HRT actually does to your risk of breast, endometrial, ovarian and other cancers, by formulation and duration, in absolute numbers rather than scary headlines. Education only; the decision is yours and your doctor or specialist's.

Why this page exists.

Most cancer-risk conversations about HRT are either alarmist (one number out of context) or dismissive ("the risk is tiny, don't worry"). Both cheat you out of the actual information. Here's the honest version: cancer by cancer, with the absolute numbers where they exist, the caveats that matter, and links to the fuller story.

If you've already had cancer and are navigating menopause alongside treatment, the page you want is Pathway: Menopause after cancer.

Breast cancer

Small absolute increase with combined HRT after several years; estrogen-only HRT doesn't appear to raise it and may slightly lower it.

The most studied and most feared number. The honest version: combined HRT (estrogen + a synthetic progestin) is associated with a small absolute increase in breast cancer risk that grows with duration of use, mostly after about 5 years. Estrogen-only HRT (used by women without a uterus) didn't show the same signal in the Women’s Health Initiative (WHI) re-analyses, and may very slightly reduce risk. Body-identical micronized progesterone appears to carry less of the signal than synthetic progestins, though the long-term data isn't as deep.

The numbers

WHI absolute numbers: about 8 extra breast cancer cases per 10,000 women per year on combined HRT, smaller than the risk attributed to drinking 2 glasses of wine a night, being 5 BMI units heavier, or smoking. Estrogen-only arm showed no increase and a possible small reduction.

Endometrial (uterine) cancer

Estrogen alone increases risk if you have a uterus. Adding adequate progesterone removes the increase.

This is the cleanest of the cancer-risk conversations. Unopposed estrogen (estrogen without progesterone) thickens the uterine lining and significantly raises endometrial cancer risk. The whole reason combined HRT exists is to prevent that. If you have a uterus and you're on estrogen, you need adequate progesterone (or a Mirena IUS, which delivers it locally). If you don't have a uterus, this concern doesn't apply to you.

The numbers

Unopposed estrogen for 5+ years: roughly 5-10x baseline endometrial cancer risk. Combined HRT with adequate progesterone: no meaningful increase, and possibly a small decrease.

Ovarian cancer

A very small absolute increase with long-term HRT use, observed mostly in long-term studies.

The signal here is real but small and mostly seen in long-duration use (10+ years). Both combined and estrogen-only HRT show a small association in observational data; the absolute numbers are very low compared to baseline ovarian cancer risk. For women with strong family history or BRCA mutations, this is a personalized conversation with the doctor or specialist; for the general population, the absolute increase is roughly 1 extra case per 1,000 women using HRT for 5 years.

Colorectal cancer

HRT slightly reduces risk, especially with combined formulations.

One of the underreported parts of the WHI: combined HRT reduced colorectal cancer incidence in the trial. The mechanism isn't fully understood. This isn't a reason to start HRT for colorectal protection (screening is what does that work), but it's part of the honest accounting when people only quote the breast cancer side of the ledger.

Cervical cancer

HRT does not increase cervical cancer risk.

Cervical cancer is overwhelmingly HPV-driven. HRT use doesn't change that. Continue cervical screening on your country's normal schedule regardless of whether you're on HRT.

Lung cancer

No clear increase from HRT; smoking remains by far the dominant risk factor.

Some early signals around HRT and lung cancer mortality in smokers haven't held up consistently. The lung cancer risk that matters is smoking history. If you smoke, the smoking conversation is the bigger one by orders of magnitude.

Vaginal estrogen and cancer risk

Local vaginal estrogen has minimal systemic absorption and is considered safe for most women, including most breast cancer survivors after individualized conversation.

The blanket 'no estrogen ever' rule that many breast cancer survivors are given for vaginal symptoms is more nuanced than it sounds. Vaginal estrogen at standard low doses delivers a tiny fraction of the systemic dose. The Menopause Society, the British Menopause Society, and several oncology bodies now support its use in many breast cancer survivors when genitourinary syndrome of menopause (GSM) is severely affecting quality of life, after a conversation with the oncology team. This is a 'talk to your specific oncologist' answer, not a website answer.

One last honest sentence about all of this.

"HRT and cancer" is almost never one number; it's a personal calculation that depends on which HRT, what dose, what formulation, how long, your age when you start, your family history, your other risk factors and what untreated symptoms are doing to your life. A doctor or specialist who talks about it as a conversation rather than a verdict is the one to keep.

For the broader picture on how HRT got mis-sold in both directions, HRT myths, honestly answered pairs with this page.

Back to treatments primer Questions to bring to your doctor or specialist